ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.990,31
0,44%
S&P 500
5.996,66
1,00%
Dow Jones
43.487,83
0,78%
Euro vs US Dollar
1,03768
-0,42%
Bitcoin
102.030,46
0,00%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Inhibrx Biosciences Inc (INBX) Börsenkurse

Inhibrx Biosciences Inc

Inhibrx Biosciences Inc (INBX)

NASDAQ
13,49
-0,05
(-0,37%)
Geschlossen 21 Januar 10:00PM
Verzögert um 15 Minuten
13,49
-0,08
(-0,59%)
Nach Börsenschluss: 12:29AM
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
13,49
Gebot
13,22
Fragen
17,64
Volumen
44.261
13,24 Tagesbereich 13,8965
10,80 52-Wochen-Bereich 39,79
Marktkapitalisierung
195,28M
Handelsende
13,54
Handelsbeginn
13,55
Letzte Trade
407
@
13.49
(priorref)
Letzter Handelszeitpunkt
Finanzvolumen
US$ 600.161
VWAP
13,5596
Durchschnittliches Volumen (3 Mio.)
74.840
Ausgegebene Aktien
14.475.904
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,27
Gewinn pro Aktie (EPS)
-10,71
Erlöse
1,63M
Nettogewinn
-154,96M

Über Inhibrx Biosciences Inc

We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence. We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence.

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
www.inhibrx.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Inhibrx Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INBX. The last closing price for Inhibrx Biosciences was US$13,54. Over the last year, Inhibrx Biosciences shares have traded in a share price range of US$ 10,80 to US$ 39,79.

Inhibrx Biosciences currently has 14.475.904 shares in issue. The market capitalisation of Inhibrx Biosciences is US$196,00 million. Inhibrx Biosciences has a price to earnings ratio (PE ratio) of -1.27.

INBX Neueste Nachrichten

Weitere Nachrichten

Inhibrx Biosciences Announces Loan Agreement with Oxford Finance

Inhibrx Biosciences Announces Loan Agreement with Oxford Finance PR Newswire SAN DIEGO, Jan. 13, 2025 SAN DIEGO, Jan. 13, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc. ("Inhibrx" or the...

13 Januar 2025
PR Newswire (US)

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results PR Newswire SAN DIEGO, Nov. 14, 2024 SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx...

14 November 2024
PR Newswire (US)

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation PR Newswire SAN DIEGO, Nov. 4, 2024 SAN DIEGO, Nov. 4, 2024 /PRNewswire/ -- Inhibrx Biosciences, Inc...

04 November 2024
PR Newswire (US)

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights PR Newswire SAN DIEGO, Aug. 13, 2024 SAN DIEGO, Aug. 13, 2024 /PRNewswire/ -- Inhibrx...

14 August 2024
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

31 Mai 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

31 Mai 2024
Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

30 Mai 2024
Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

30 Mai 2024
Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

30 Mai 2024
Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

30 Mai 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.8-5.5983205038514.2914.954712.5111058213.43774958CS
4-0.16-1.1721611721613.6516.8312.518345014.44931051CS
12-2.08-13.359023763615.5717.4112.257484014.80142035CS
26-0.61-4.3262411347514.117.7910.88715814.69451403CS
52-20.94-60.819053151334.4339.7910.835409431.04364874CS
156-17.33-56.229720960430.8239.797.6742389324.95764279CS
260-6.21-31.522842639619.750.977.6733895625.83414866CS

INBX - Frequently Asked Questions (FAQ)

What is the current Inhibrx Biosciences share price?
The current share price of Inhibrx Biosciences is US$ 13,49
How many Inhibrx Biosciences shares are in issue?
Inhibrx Biosciences has 14.475.904 shares in issue
What is the market cap of Inhibrx Biosciences?
The market capitalisation of Inhibrx Biosciences is USD 196M
What is the 1 year trading range for Inhibrx Biosciences share price?
Inhibrx Biosciences has traded in the range of US$ 10,80 to US$ 39,79 during the past year
What is the PE ratio of Inhibrx Biosciences?
The price to earnings ratio of Inhibrx Biosciences is -1,27
What is the cash to sales ratio of Inhibrx Biosciences?
The cash to sales ratio of Inhibrx Biosciences is 120,19
What is the reporting currency for Inhibrx Biosciences?
Inhibrx Biosciences reports financial results in USD
What is the latest annual turnover for Inhibrx Biosciences?
The latest annual turnover of Inhibrx Biosciences is USD 1,63M
What is the latest annual profit for Inhibrx Biosciences?
The latest annual profit of Inhibrx Biosciences is USD -154,96M
What is the registered address of Inhibrx Biosciences?
The registered address for Inhibrx Biosciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Inhibrx Biosciences website address?
The website address for Inhibrx Biosciences is www.inhibrx.com
Which industry sector does Inhibrx Biosciences operate in?
Inhibrx Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
BTCTBTC Digital Ltd
US$ 8,2697
(73,73%)
61,45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8,80
(62,36%)
18,63M
CRKNCrown Electrokinetics Corporation
US$ 0,1235
(54,96%)
764,86M
NUKKNukkleus Inc
US$ 29,97
(45,98%)
19,09M
GSITGSI Technology
US$ 3,97
(44,36%)
87,7M
DOGZDogness International Corporation
US$ 18,23
(-58,77%)
740,45k
ORKTOrangeKloud Technology Inc
US$ 3,02
(-24,88%)
21,08M
PMAXPowell Max Ltd
US$ 0,6364
(-23,31%)
4,17M
LGCBLinkage Global Inc
US$ 0,2876
(-22,27%)
890,66k
YYAIConnexa Sports Technologies Inc
US$ 0,8299
(-20,20%)
602,48k
CRKNCrown Electrokinetics Corporation
US$ 0,1235
(54,96%)
764,86M
GCTKGlucoTrack Inc
US$ 0,0852
(15,45%)
465,22M
RIMEAlgorhythm Holdings Inc
US$ 0,0406
(-4,02%)
387,23M
TGLTreasure Global Inc
US$ 0,2459
(14,75%)
267,1M
NVDANVIDIA Corporation
US$ 137,71
(3,10%)
201,4M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
INBX
Inhibrx Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten